SCHEMBL8669883

SCHEMBL8669883

CC(=O)Nc1ccc2c(c1)CC(NC(C)=O)C2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.60
CA2 P00918 3/20 0.60
CA12 O43570 2/20 0.60
CA7 P43166 2/20 0.60
CA14 Q9ULX7 2/20 0.60
CA9 Q16790 1/20 0.58
APOB P04114 5/20 0.56
MTTP P55157 5/20 0.56
CYP1A2 P05177 1/20 0.51
ADRA2A P08913 1/20 0.51
MAOA P21397 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR2C P28335 1/20 0.51
SLC6A4 P31645 1/20 0.51
HTR2B P41595 1/20 0.51
MTNR1A P48039 2/20 0.50
MTNR1B P49286 2/20 0.50
GRIA2 P42262 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3805053 0.87 CA1 (0.56) CA1CA2CA12CA7CA14
SCHEMBL8006294 0.87 CA1 (0.56) CA1CA2CA12CA7CA14
SCHEMBL2246315 0.83 CYP1A2 (0.54) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL28744228 0.82 NPC1 (0.52) CA1CA2CA12CA7CA14
SCHEMBL10405252 0.82 CA1 (0.61) CA1CA2CA12CA7CA14
SCHEMBL7763156 0.81 APOB (0.62) CA1CA2CA12CA7CA14
SCHEMBL9505624 0.80 CA1 (0.63) CA1CA2CA12CA7CA14
SCHEMBL23519580 0.79 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL2249768 0.79 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL25086307 0.79 HTR2C (0.50) CYP1A2ADRA2AMAOASLC6A2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
WO-1998005651-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYL QUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1998-02-12 WO disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed